It just means placebo response was as good as NTCELL. Doesn't look like a pooled analysis would do anything either as some on NTCELL 120 were worse than baseline.
They will probably need to wait 1-2 years and hope everyone stays on the follow up protocol for the trial to wait for placebo to get worse but at that point hard to tell why placebo got worse compared to the NTCELL arm.
Disappointing all around. I've sold out today.
- Forums
- ASX - By Stock
- 1AI
- Ann: Results of LCT Parkinsons trial require further analysis
Ann: Results of LCT Parkinsons trial require further analysis, page-17
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.18M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.9¢ | $386 | 42.91K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 163615 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 633746 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 163615 | 0.009 |
12 | 5396180 | 0.008 |
8 | 6360009 | 0.007 |
6 | 2493750 | 0.006 |
4 | 2300000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 633746 | 2 |
0.011 | 1281697 | 10 |
0.012 | 2385405 | 7 |
0.013 | 894768 | 4 |
0.014 | 126665 | 2 |
Last trade - 10.09am 15/07/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online